Financhill
Sell
29

VOR Quote, Financials, Valuation and Earnings

Last price:
$8.30
Seasonality move :
25.81%
Day range:
$8.03 - $8.49
52-week range:
$2.62 - $65.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.13x
Volume:
435.6K
Avg. volume:
827.3K
1-year change:
-53.43%
Market cap:
$57M
Revenue:
--
EPS (TTM):
-$381.91

Earnings Data

Next earnings date for VOR
Mar 26
2026
Most recent earnings per share
-$121.63
Missed by $117.53
(Nov 13/2025)
Consensus Estimate
-$4.10
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VOR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/26/2026 Q4 -- -- -- -$1.06 --
11/13/2025 Q3 -- -- -$121.63 -$4.10 -$117.53
08/13/2025 Q2 -- -- -$251.24 -$11.80 -$239.44
05/08/2025 Q1 -- -- -$0.26 -$4.16 $3.90
03/20/2025 Q4 -- -- -$8.78 -$6.13 -$2.65
11/07/2024 Q3 -- -- -$0.40 -$8.09 $7.68
08/08/2024 Q2 -- -- -$0.41 -$8.29 $7.88
05/09/2024 Q1 -- -- -$0.45 -$7.63 $7.18
03/20/2024 Q4 -- -- -$0.39 -$9.94 $9.56
11/07/2023 Q3 -- -- -$0.49 -$9.17 $8.68
08/10/2023 Q2 -- -- -$0.45 -- --
05/11/2023 Q1 -- -- -$0.43 -- --
03/23/2023 Q4 -- -- -$0.51 -- --
11/10/2022 Q3 -- -- -$0.63 -- --
08/11/2022 Q2 -- -- -$0.58 -- --
05/12/2022 Q1 -- -- -$0.61 -- --
03/14/2022 Q4 -- -- -$0.49 -- --
11/10/2021 Q3 -- -- -$0.50 -- --
08/09/2021 Q2 -- -- -$0.50 -- --
05/06/2021 Q1 -- -- -$0.41 -- --
12/31/2020 Q4 -- -- -$0.48 -- --
09/30/2020 Q3 -- -- -$0.38 -- --
06/30/2020 Q2 -- -- -$0.24 -- --
03/31/2020 Q1 -- -- -$0.23 -- --
12/31/2019 Q4 -- -- -$0.12 -- --
09/30/2019 Q3 -- -- -$0.11 -- --

Vor Biopharma, Inc. Earnings Questions

  • How Much did Vor Biopharma, Inc. Generate in Revenue Last Quarter?

    Vor Biopharma, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Vor Biopharma, Inc. Beat Earnings Last Quarter?

    Vor Biopharma, Inc. announced earnings per share of -$121.63 which represents a miss of analyst forecast a -$4.10 per share.

  • Is Vor Biopharma, Inc. Profitable?

    Vor Biopharma, Inc. reported -$2K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Vor Biopharma, Inc. EPS Next Year?

    Vor Biopharma, Inc.'s earnings are forecast to decrease from -$34.03 per share to -$29.27 per share next year representing a decrease of -108.33%.

  • When is Vor Biopharma, Inc.'s Earnings Date?

    Vor Biopharma, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock